Starts & Stops: Livongo Launches SUGAR Trial Of Connected Meter; Luminor Completes TINTIN Study Of Luminor Balloon
Executive Summary
Starts & Stops compiles all the clinical trial announcements, initiations, completions and suspensions tracked by Meddevicetracker. This edition covers trial announcements from Nov. 5 through Nov. 11, including trial announcements from iVascular, Simplify Medical, Livongo Health, and Bio2 Technologies.
You may also be interested in...
Livongo Names Zane Burke New CEO; Jennifer Schneider Becomes President
Zane Burke is the new CEO of Livongo Health, the applied health signals company announced Dec. 18. Burke previously spent five years as president of health IT company Cerner Corp. Livongo also announced that Chief Medical Officer Jennifer Schneider has been promoted to president, overseeing product, data science, software engineering, marketing, and clinical operations.
Market Intel: Managing Diabetes With Digital Apps: Physicians' Views On Pros And Cons
With a growing number of diabetes apps on the market, patients and physicians can obtain a large amount of data to help manage the disease. In this second part of a two-part series on the blood glucose monitoring devices market, two endocrinologists express their views on the considerations and pitfalls of using apps to help manage diabetes, and they recommend specific apps.
News We’re Watching: FDA Approves Medtronic's Affera, Roche's CGM Moves Closer To Approval, And More
Medtech Insight's News We're Watching covers medtech industry and research news you may have missed. This week, the Advanced Technologies and Treatments for Diabetes (ATTD) conference in Florence, Italy, included new results from studies of Roche's continuous glucose monitor and Medtronic's 780G insulin pump, Medtronic moved closer to earning FDA approval for its Affera ablation mapping and ablation system, and Linus Health expanded its technology for finding signs of cognitive problems in speech data.